In HCC, NSUN2 contributes to tumor progression by up-regulating PKM2 and stabilizing its mRNA, thereby promoting glycolysis and offering potential therapeutic avenues for HCC patients (48). This evidence concerns the gene NSUN2 and hepatocellular carcinoma.